Dear Dr. Renukaprasad A R, The advances in recombinant DNA technologies have led to both rapid- and long-acting human insulin analogs administered via the subcutaneous route, which better mimics the physiology of insulin secretion, leading to the modern basal-bolus regimen. This enables people with diabetes to meet their individual glycemic goals effectively. On the occasion of our 9th anniversary, we bring you an exclusive DIWAS session on "Insulin and its Analogs: Options, Formulations, and Efficacy" by experts in the field. Join us on 6th October 2022, 6:00 PM IST onwards! Speaker: Dr. Lakshmi Hariharan Topic: Insulin- Options and formulations Session Highlights: - Types of insulin
- Physiology of insulin secretion
- Short-acting and long-acting analogs
Speaker: Dr. J S Kumar Topic: Insulin analogs: Efficacy, pros and cons Session Highlights: - Basal insulin analogs
- Pre-mix insulin analogs
- Value of insulin analogs
|
No comments:
Post a Comment